Theravance (NASDAQ:THRX) major shareholder Plc Glaxosmithkline purchased 172,651 shares of the stock in a transaction dated Monday, August 11th. The shares were purchased at an average price of $3,912,270.00 per share, for a total transaction of $ ... ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home